Cancer Research UK, which funded the study, believe that if further trials prove successful, a single bankof T-cells could serve as a global source of immune cells to treat the condition.
Arthur Caplan, Professor of Bioethics at University of Pennsylvania, and Robin Smith, CEO of NeoStem, U.S. based firm which helps people bank their own stem cells for possible future use.